OraVescent Fentanyl (OVF) for the Treatment of Breakthrough Pain in Opioid Tolerant Cancer Patients

This study has been completed.

Study NCT00105937 Information provided by Cephalon

First Received: March 18, 2005 Last Updated: May 25, 2007 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	November 2006
Estimated Primary Completion Date:	No date given